LYMPHATICA MEDTECH CLOSES € 17.9 M SERIES B FUNDING ROUND TO DRIVE INNOVATION IN LYMPHEDEMA TREATMENT
SamanTree Medical Achieves FDA Clearance for Histolog® Scanner, Ushering in a New Era of Tissue Imaging in the U.S.
CorFlow Therapeutics AG Completes €44 Million Series B Financing to Support the Advancement...
Lenire Controlled Clinical Trial Results Published in Nature Communications
SamanTree Medical Raises $14M in Series B Financing Round to Support Global Expansion and Innovation in Surgical Treatment
Diadem Appoints Michael Rasche as Chief Executive Officer
BetaGlue™ Adds €8m Equity Financing to €10m EIC Accelerator Award
Endostart receives FDA 510(k) clearance for Endorail®, ushering in new era of gastrointestinal endoscopy innovation
MMI Receives FDA Authorization to Commercialize Symani® Surgical System in the U.S.
MMI Raises $110 Million in Series C Financing
Enterprise Therapeutics Closes £26 million ($33.1 million) Series B Follow-on Financing
Panakes Partners Welcomes Federica Porcu as ESG and Financial Accounting Manager
DISCO Pharmaceuticals launches as the surfaceome company with EUR 20 Million in Seed Financing
Nouscom Raises €67.5 million ($72 million) in Oversubscribed Series C Financing Round
Panakes Partners Welcomes New Network and Portfolio Talent Advisor to Drive Growth and Innovation
Italian - American Allotex Secures 30m$ Funding for Allogeneic Presbyopia Inlays
First patient receiving groundbreaking neuromodulation solution for severe migraine and cluster headaches
Carthera closes $40M Series B to support SonoCloud
EBAMed, Swiss-Italian Company, raises EUR 14.35 Million in Series A Funding to develop its novel image guidance system for the non-invasive treatment of Ventricular Tachycardia
COMPLEMENT THERAPEUTICS SECURES €72 MILLION IN SERIES A FINANCING TO ADVANCE NOVEL THERAPIES TARGETING COMPLEMENT-MEDIATED DISEASES
NEUROMOD CLOSES €30 MILLION FINANCING TO EXPAND AVAILABILITY OF LENIRE®
PANAKÈS PARTNERS ANNOUNCES THE FINAL CLOSING OF THE “PURPLE” FUND AT 175 MILLION EUROS
Approxima closed a € 1.6M seed financing round for the development
Medical Microinstruments Secures $75M to Advance Robotic Microsurgery
BetaGlue Technologies: closing of a EUR 10 million financing round
Vivasure Medical Announces Series D Financing to Advance Portfolio of PerQseal Vessel Closure Devices
DIADEM ANNOUNCES FIRST CLOSING OF €10 MILLION EQUITY FINANCING FOR ITS AlzoSure® PREDICT PROGNOSTIC BLOOD TEST FOR ALZHEIMER'S DISEASE
PANAKES PARTNERS ANNOUNCES THE PROMOTION OF ALESSIO PIUMA AS INVESTMENT MANAGER AND GIACOMO PICCININI AS ASSOCIATE
INNOVHEART RAISES $55 MILLION IN SERIES C FINANCING TO FURTHER DEVELOP THE TRANS-SEPTAL REPLACEMENT SYSTEM
PANAKÈS PARTNERS APPOINTS DR. ROB WOODMAN AS PARTNER TO LEAD BIOTECH INVESTMENT
Panakes Partners Announces the hiring of Dr. Marco Sardina as Scientific Partner and Dr. Andrea Ballerini as Associate
PANAKÈS PARTNERS ANNOUNCES THE FIRST CLOSING OF ITS NEW “PURPLE” GLOBAL BIOTECH/ MEDTECH
Salvia BioElectronics B.V. ("Salvia"), a neurostimulation platform company targeting chronic migraine, announces today the appointment
CarThera, a French company that designs and develops innovative ultrasound-based medical devices to treat brain disorders, today announces preclinical results
Endostart,startup toscana che ha sviluppato una piattaforma endoscopica che mira alle colonscopie incomplete, già certificata ISO13485
Diadem srl, a company developing the first blood-based test for the early prediction of Alzheimer's disease (AD)
Vivasure Medical®, a company pioneering fully absorbable solutions for large hole percutaneous vessel closure, today announced Andrew Glass has assumed the role of chief executive
Panakès Partners sgr, società di venture capital specializzata in investimenti in aziende innovative nel settore delle scienze della vita, ha nominato partner Barbara Castellano
Aileens Pharma, società di biotecnologia impegnata nella ricerca clinica, attiva nello sviluppo di trattamenti per le malattie della pelle
Diadem srl, a company developing the first blood-based test for the early prediction of Alzheimer's disease (AD), today announced the publication of three new scientific studies
Medical Microinstruments (MMI) SpA, a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, announced today the hiring of Mark Toland
InnovHeart s.r.l., a developer of novel Transcatheter Mitral Valve Replacement (TMVR) systems for the treatment of Mitral Regurgitation, announced today the appointment
Diadem srl, a company developing the first blood-based test for the early prediction of Alzheimer's disease (AD), today reported that it hosted a Symposium on its prognostic biomarker
Diadem srl, a company developing the first blood-based test for the early prediction of Alzheimer's disease (AD), today announced that noted neuroscientist and Alzheimer's
On the heels of its recent US launch, Echolight Medical announces the hiring of several industry heavyweights, not only in radiology but specifically in point-of-care service.
Salvia BioElectronics receives FDA Breakthrough Device Designation for innovative neurostimulation solution
MMI SpA Launches Breakthrough Technology, Advancing Robotic Microsurgery with the World’s Smallest Wristed Surgical Instruments
Diadem Names Clinical Diagnostics Industry Veteran Paul Kinnon as CEO
EU backs MMI’s Robotic System for Microsurgery
InnovHeart Reports Successful First-in- Human Implantation of its Saturn Transcatheter Mitral Valve with Excellent 30-day Follow-up
Salvia BioElectronics raises EUR 26M (USD 31M) to develop innovative neurostimulation therapy for chronic migraine
CarThera to receive €2M grant and €10.5M equity from the European Innovation Council
Olympus Strikes Exclusive Deal to Distribute Ultravision Surgical Smoke Management System in the U.S.
Transcatheter Mitral Valve Replacement Company InnovHeart Closes Series B Financing of €20 Million
SamanTree Medical Raises CHF 9.5 Million to Assess the Margins in Cancer Surgery
Diadem, an academic spin-off active in early Alzheimer diagnostic, raises €1,5 million in its A Round led by Panakes Partners
Endostart, an Italian startup aiming at reducing endoscopic procedures’ complexity, raised €1 million in its seed round of financing
CarThera closes €9M ($10.3M) Series B funding round
Aileens Pharma S.r.l. Announces €3M in Series A Funding to advance the development of a wave of Innovative Non-Steroidal Treatments for Dermatologic disorders
Medical Microinstruments S.p.A. Announces €20M in Series A Funding to Advance its Robotic Platform for Microsurgery
Alesi Surgical raises €6m (£5.2m) to accelerate commercialisation of breakthrough product UltravisionTM
Vivasure Medical Announces €16.2M ($18.3M) in Financing to Advance Commercialization of Closure Device in European Union and United States
Seventeen, a startup aiming to disrupt loco-regional therapies for solid tumors, raised a Series A for more than €4 million
Medtech Startup Echolight Raises €4M in Series A Funding
Panakès Partners SGR announces the arrival of Barbara CASTELLANO as part of the investment team
Partners SGR launches its first Venture Capital Fund dedicated to European Medtech startups.